FTC sues three largest drug middlemen for allegedly inflating insulin prices

3 hours ago 4

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” inflating the list price of insulin. The agency’s action targeted CVS Caremark Rx, Cigna’s Express Scripts and UnitedHealth’s OptumRx. The three companies combined administer about 80 percent of all prescriptions…

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Bdtype.

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.bdtype.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article